IMU 0.00% 5.8¢ imugene limited

Ann: Phase 1 onCARlytics Trial Advances to Combination Arm, page-9

  1. 2,867 Posts.
    lightbulb Created with Sketch. 11919
    Hi GMT2!

    Yes - more good news. Expected - but still good to hear.

    I also find it interesting that IMU mentions Gilead's Yescarta. They used similar wording back in October. Gilead has been pushing hard in the CAR-T space and sees it as the future. They paid a shirt load to buy Kite Pharma, who developed Yescarta. $11.9b USD, I believe.

    You would have to think that Gilead has been watching OnCARlytics with considerable interest. For that matter - also Azer-Cel.

    Cheers

    Dave



 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.8¢
Change
0.000(0.00%)
Mkt cap ! $424.5M
Open High Low Value Volume
5.7¢ 5.8¢ 5.5¢ $954.9K 16.98M

Buyers (Bids)

No. Vol. Price($)
8 847774 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.8¢ 1472351 8
View Market Depth
Last trade - 16.10pm 17/06/2024 (20 minute delay) ?
Last
5.6¢
  Change
0.000 ( 1.93 %)
Open High Low Volume
5.7¢ 5.7¢ 5.5¢ 5009307
Last updated 15.59pm 17/06/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.